Skip to main content

Table 1 Patient demographics and SSN characteristics

From: Predicting malignant potential of subsolid nodules: can radiomics preempt longitudinal follow up CT?

Number of patients

36

Male: Female

5:31

Number of SSNs (benign: malignant)

108 (31:77)

Patients with ≥3 SSNs

23 (36)

Mean age at baseline

69 ± 8 years

Mean age at follow-up

73 ± 8 years

Mean time intervals between baseline and follow-up

55 ± 32 months

Average size of SSNs at baseline (benign: malignant)

13.2 ± 6 mm: 12.7 ± 7 mm

Average size of SSNs at follow-up (benign: malignant)

13.3 ± 6 mm: 21.3 ± 17 mm